IPSC - Century Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$2.00
DETAILS
HIGH:
$2.00
LOW:
$2.00
MEDIAN:
$2.00
CONSENSUS:
$2.00
DOWNSIDE:
3.38%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 88.0% |
| EBIT Margin | -8.8% |
| EBITDA Margin | 3.2% |
| Operating Margin | -13.8% |
| Pretax Margin | -8.8% |
| Cont. Ops Margin | -8.8% |
| Net Margin | -8.8% |
| Bottom Line Margin | -8.8% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 5.97 |
| Quick Ratio | 5.97 |
| Solvency Ratio | 0.054 |
| Cash Ratio | 3.06 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-9.04
Peers avg: 72.1
|
| PEG Ratio | 0.10 |
| Forward PEG | 0.10 |
| Price/Book | 0.54 |
| Price/Sales | 0.79 |
| Price/FCF | -0.82 |
| Price/Op Cash Flow | -0.83 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.1947 |
| Debt/Equity | 0.2741 |
| Debt/Capital | 0.2151 |
| Long-Term Debt/Capital | 0.0000 |
| Financial Leverage | 1.41 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 1.32 |
| Operating Cash Flow Ratio | -5.136 |
| Operating Cash Flow/Sales | -95.2% |
| Free Cash Flow/Operating Cash Flow | 100.8% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | 0.00 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | 0.00 |
| Operating Cash Flow Coverage | -2.38 |
| Capital Expenditure Coverage | -122.50 |
| Dividend + Capital Expenditure Coverage | -122.50 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 1.26 |
| EPS | -0.111 |
| Debt/Share | 0.5033 |
| Cash/Share | 1.35 |
| Book Value/Share | 1.84 |
| Tangible BV/Share | 1.44 |
| Equity/Share | 1.84 |
| Operating Cash Flow/Share | -1.200 |
| Capital Expenditure/Share | 0.010 |
| FCF/Share | -1.210 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 0.993 |
| Earnings Before Tax/EBIT | 0.641 |
| Price/Fair Value | 0.54 |
| Debt/Market Cap | 0.0000 |
| Effective Tax Rate | 0.7% |
| Enterprise Value Multiple | 19.64 |